Search

• GSK launches first call for proposals for research in to non-communicable diseases in sub-Saharan Africa

  Media

  GSK launched first call for proposals for its Africa NCD Open Lab, to support much-needed scientific research into NCDs in Africa.

  https://www.gsk.com/en-gb/media/press-releases/gsk-launches-first-call-for-proposals-for-research-in-to-non-communicable-diseases-in-sub-saharan-africa/

  First published: 14 November 2014

• GSK leads Access to Medicine Index 2014

  Media

  The Access to Medicines Index published today has ranked GSK top for the fourth consecutive time.

  https://www.gsk.com/en-gb/media/press-releases/gsk-leads-access-to-medicine-index-2014/

  First published: 17 November 2014

• GSK and Save the Children launch 2015 call for developing country healthcare innovations to reduce child deaths

  Media

  GSK and Save the Children announce the launch of their third annual $1 million Healthcare Innovation Award.

  https://www.gsk.com/en-gb/media/press-releases/gsk-and-save-the-children-launch-2015-call-for-developing-country-healthcare-innovations-to-reduce-child-deaths/

  First published: 15 July 2015

• GSK extends its price-freeze commitment to ten years for countries graduating from Gavi support

  Media

  New extended price freeze enables countries that graduate from Gavi support to continue to pay the same discounted price for GSK vaccines

  https://www.gsk.com/en-gb/media/press-releases/gsk-extends-its-price-freeze-commitment-to-ten-years-for-countries-graduating-from-gavi-support/

  First published: 26 January 2015

• GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

  Media

  GSK announced a £5m collaboration with UK and SAMRC, to support much-needed research into NCDs in Africa, part of GSK Open Lab initiative.

  https://www.gsk.com/en-gb/media/press-releases/gsk-joins-with-research-councils-in-uk-and-south-africa-to-tackle-non-communicable-diseases-in-africa/

  First published: 09 September 2014

• Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate

  Media

  Based on the positive Phase 1 results, Medicago has decided to launch the Phase 2/3 clinical trial with GSK’s pandemic adjuvant.

  https://www.gsk.com/en-gb/media/press-releases/medicago-and-gsk-announce-start-of-phase-23-clinical-trials-of-adjuvanted-covid-19-vaccine-candidate/

  First published: 12 November 2020

• CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus

  Media

  GSK to make adjuvant technology available to support rapid development of candidate vaccines

  https://www.gsk.com/en-gb/media/press-releases/cepi-and-gsk-announce-collaboration-to-strengthen-the-global-effort-to-develop-a-vaccine-for-the-2019-ncov-virus/

  First published: 03 February 2020

• GSK and Vir Biotechnology enter collaboration to find coronavirus solutions

  Media

  Companies will combine their unique scientific and technical expertise to combat COVID-19 and potential future coronavirus outbreaks.

  https://www.gsk.com/en-gb/media/press-releases/gsk-and-vir-biotechnology-enter-collaboration-to-find-coronavirus-solutions/

  First published: 06 April 2020

• GSK sets out further steps to address emerging global health security challenges

  Media

  GSK will set out a series of steps to further address emerging global health challenges

  https://www.gsk.com/en-gb/media/press-releases/gsk-sets-out-further-steps-to-address-emerging-global-health-security-challenges/

  First published: 19 September 2016

• GSK strengthens vaccines business with acquisition of Okairos

  Media

  GSK announced it's acquired Okairos, a specialist developer of vaccine platform technologies for €250 million (approx. £215/$325 million)

  https://www.gsk.com/en-gb/media/press-releases/gsk-strengthens-vaccines-business-with-acquisition-of-okairos/

  First published: 29 May 2013